AARTI PHARMALABS LIMITED

AARTIPHARM

Small Cap | Pharmaceuticals
776.8
-6.54 (-0.83%)

Stock price as on 06 Feb 2026 at 15:30 PM

Aarti pharmalabs limited share price update

As of the latest trading session, Aarti Pharmalabs Limited share price is currently at ₹776.8, which is down by ₹-6.54 from its previous closing. Toda...

Aarti Pharmalabs Limited stock performance

Today’s low

₹763.45

Today’s high

₹785

₹776.8

52 week low

₹574.45

52 week high

₹971

₹776.8
Open
₹783.35
Previous close
₹783.35
Share volume
1,07,929
Total traded value (Lakh)
₹838.39
Upper circuit
₹940.00
Lower circuit
₹626.70

Aarti Pharmalabs Limited fundamentals

Market cap (Cr)
₹7,041.50
P/E ratio (TTM)
28.83
Book value per share
₹210.00
Beta
1.03
Return on equity
14.85%
Earnings per share (TTM)
₹26.97
Dividend yield
0.64%
Net profit/quarter (Cr)
₹30.93

Aarti Pharmalabs Limited financials

(Values in Cr)
Revenue
Net income

Particulars

Sep 25 (₹ value in crores)

Revenue

₹417.29

Operating expense

₹378.73

Net income

₹30.93

Net profit margin

7.41%

Earning per share

₹3.41

EBITDA

₹77.13

Effective tax rate

25.82%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹375.31

Operating expense

₹309.73

Net income

₹51.22

Net profit margin

13.64%

Earning per share

₹5.65

EBITDA

₹96.72

Effective tax rate

23.74%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹529.62

Operating expense

₹413.62

Net income

₹88.85

Net profit margin

16.77%

Earning per share

₹9.80

EBITDA

₹140.62

Effective tax rate

21.72%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹470.95

Operating expense

₹386.70

Net income

₹73.52

Net profit margin

15.61%

Earning per share

₹8.11

EBITDA

₹126.92

Effective tax rate

23.55%

Particulars

Sep 24 (₹ value in crores)

Revenue

₹377.29

Operating expense

₹316.80

Net income

₹47.84

Net profit margin

12.67%

Earning per share

₹5.28

EBITDA

₹87.71

Effective tax rate

24.59%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹1,771.35

Operating expense

₹1,449.50

Net income

₹257.35

Net profit margin

14.52%

Earning per share

₹28.39

EBITDA

₹441.03

Effective tax rate

23.48%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹1,502.13

Operating expense

₹1,238.62

Net income

₹200.65

Net profit margin

13.35%

Earning per share

₹22.14

EBITDA

₹357.15

Effective tax rate

26.9%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹1,511.25

Operating expense

₹1,279.17

Net income

₹171.73

Net profit margin

11.36%

Earning per share

₹18.95

EBITDA

₹309.62

Effective tax rate

26.4%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹941.02

Operating expense

₹809.80

Net income

₹106.73

Net profit margin

11.34%

Earning per share

₹11.78

EBITDA

₹182.29

Effective tax rate

20.18%

Particulars

Mar 21 (₹ value in crores)

Revenue

-

Operating expense

-

Net income

-

Net profit margin

-

Earning per share

-₹0.18

EBITDA

-

Effective tax rate

-

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹219.55

Return on Equity (ROE)

14.54%

Return on Capital Employed (ROCE)

17.35%

Total debt to equity ratio

0.19

EBITDA margin

22.43%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹193.88

Return on Equity (ROE)

13.08%

Return on Capital Employed (ROCE)

16.6%

Total debt to equity ratio

0.15

EBITDA margin

21.1%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹171.97

Return on Equity (ROE)

13.14%

Return on Capital Employed (ROCE)

16.07%

Total debt to equity ratio

0.19

EBITDA margin

17.7%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹53,646.60

Return on Equity (ROE)

17.63%

Return on Capital Employed (ROCE)

19.37%

Total debt to equity ratio

0.25

EBITDA margin

17.46%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹9.12

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

0.09

EBITDA margin

-

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹203.44

Return on Equity (ROE)

14.85%

Return on Capital Employed (ROCE)

17.33%

Total debt to equity ratio

0.2

EBITDA margin

24.9%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹178.92

Return on Equity (ROE)

13.11%

Return on Capital Employed (ROCE)

16.4%

Total debt to equity ratio

0.16

EBITDA margin

23.78%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹158.74

Return on Equity (ROE)

12.61%

Return on Capital Employed (ROCE)

15.56%

Total debt to equity ratio

0.2

EBITDA margin

20.49%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹49,558.52

Return on Equity (ROE)

16.62%

Return on Capital Employed (ROCE)

18%

Total debt to equity ratio

0.25

EBITDA margin

19.37%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹9.07

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

0.01

EBITDA margin

-

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹8.64

Total assets

₹2,906.40

Total liabilities

₹2,906.40

Total equity

₹1,989.90

Shares outstanding

₹9.06

Price to book ratio

₹3.68

Return on assets (%)

9.37%

Return on capital

11.42%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹24.06

Total assets

₹2,582.10

Total liabilities

₹2,582.10

Total equity

₹1,757.03

Shares outstanding

₹9.06

Price to book ratio

₹2.43

Return on assets (%)

8.4%

Return on capital

10.73%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹12.19

Total assets

₹2,244.02

Total liabilities

₹2,244.02

Total equity

₹1,558.48

Shares outstanding

₹9.06

Price to book ratio

₹1.73

Return on assets (%)

8.62%

Return on capital

10.91%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹83.27

Total assets

₹2,039.89

Total liabilities

₹2,039.89

Total equity

₹1,386.47

Shares outstanding

₹0.02

Price to book ratio

-

Return on assets (%)

5.99%

Return on capital

7.09%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹0.25

Total assets

₹0.25

Total liabilities

₹0.25

Total equity

₹0.22

Shares outstanding

₹0.02

Price to book ratio

-

Return on assets (%)

-1.83%

Return on capital

-1.87%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹3.52

Total assets

₹2,723.60

Total liabilities

₹2,723.60

Total equity

₹1,843.87

Shares outstanding

₹9.06

Price to book ratio

₹3.68

Return on assets (%)

9.44%

Return on capital

11.5%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹4.42

Total assets

₹2,296.91

Total liabilities

₹2,296.91

Total equity

₹1,621.45

Shares outstanding

₹9.06

Price to book ratio

₹2.43

Return on assets (%)

8.73%

Return on capital

10.72%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹0.37

Total assets

₹1,976.36

Total liabilities

₹1,976.36

Total equity

₹1,438.57

Shares outstanding

₹9.06

Price to book ratio

₹1.73

Return on assets (%)

8.68%

Return on capital

10.44%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹56.49

Total assets

₹1,826.83

Total liabilities

₹1,826.83

Total equity

₹1,284.27

Shares outstanding

₹0.02

Price to book ratio

-

Return on assets (%)

5.84%

Return on capital

6.63%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹0.25

Total assets

₹0.25

Total liabilities

₹0.25

Total equity

₹0.22

Shares outstanding

₹0.02

Price to book ratio

-

Return on assets (%)

-1.83%

Return on capital

-2.03%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹360.68

Cash from operations

₹396.08

Cash from investing

-₹413.89

Cash from financing

₹65.43

Net change in cash

-₹16.90

Free cash flow

₹798.12

Particulars

Mar 24 (₹ value in crores)

Net income

₹300.49

Cash from operations

₹273.29

Cash from investing

-₹214.56

Cash from financing

₹9.72

Net change in cash

₹11.51

Free cash flow

₹428.89

Particulars

Mar 23 (₹ value in crores)

Net income

₹260.77

Cash from operations

₹312.49

Cash from investing

-₹157.80

Cash from financing

-₹163.46

Net change in cash

-₹71.15

Free cash flow

₹414.62

Particulars

Mar 22 (₹ value in crores)

Net income

₹155.38

Cash from operations

-₹22.57

Cash from investing

-₹138.73

Cash from financing

₹260.38

Net change in cash

₹77.94

Free cash flow

₹118.57

Particulars

Mar 21 (₹ value in crores)

Net income

-

Cash from operations

-

Cash from investing

-

Cash from financing

-

Net change in cash

-

Free cash flow

-

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹336.34

Cash from operations

₹398.50

Cash from investing

-₹419.80

Cash from financing

₹78.63

Net change in cash

-₹1.16

Free cash flow

₹789.98

Particulars

Mar 24 (₹ value in crores)

Net income

₹274.51

Cash from operations

₹230.68

Cash from investing

-₹184.39

Cash from financing

₹4.39

Net change in cash

₹3.69

Free cash flow

₹376.64

Particulars

Mar 23 (₹ value in crores)

Net income

₹233.35

Cash from operations

₹272.61

Cash from investing

-₹115.55

Cash from financing

-₹156.52

Net change in cash

-₹56.19

Free cash flow

₹371.53

Particulars

Mar 22 (₹ value in crores)

Net income

₹133.72

Cash from operations

-₹49.84

Cash from investing

-₹133.53

Cash from financing

₹254.62

Net change in cash

₹56.24

Free cash flow

₹86.18

Particulars

Mar 21 (₹ value in crores)

Net income

-

Cash from operations

-

Cash from investing

-

Cash from financing

-

Net change in cash

-

Free cash flow

-

Aarti Pharmalabs Limited technical summary

₹776.8
-0.83 ▼
11
Bearish
5
Bullish
5 Day776.4
10 Day772.1
12 Day770.9
20 Day766.8
26 Day764.5
50 Day763.8
100 Day777.7
200 Day779.3
5 Day780.9
10 Day767.3
12 Day766.8
20 Day770
26 Day762.8
50 Day748.3
100 Day782.9
200 Day823.1

781.9

PIVOT

First support
₹774.00
First resistance
₹791.25
Second support
₹764.65
Second resistance
₹799.15
Third support
₹756.75
Third resistance
₹808.50
RSI
53.09
ADX
18.12
MACD
6.39
Williams % R
-34.92
Commodity Channel Index (CCI)
28.99
Date
06 Feb 2026
Same day
40,806
Week
53,574
Month
87,579
1 year
1.03
3 years
0.92
Over 1 month
5.41%
Over 1 year
14.24%
Over 3 months
-7.95%
Over 3 years
41.79%
Over 6 months
-4.96%
Over 6 years
0%

Investment Returns

Over 1 Month5.41%
Over 3 Months7.95%
Over 6 Months4.96%
Over 1 Year14.24%

Aarti Pharmalabs Limited Shareholding pattern


Public
41.55%
Promoter holdings
43.09%
FII
7.68%
DII
7.66%
Promoter shares
0.01%
Promoter sharesShareCategory

Life Insurance Corporation Of India

47,82,452 (5.28%)

Public Shareholding

Rashesh Chandrakant Gogri

38,34,404 (4.23%)

Shareholding of Promoter and Promoter Group

Jaya Chandrakant Gogri

32,04,310 (3.53%)

Shareholding of Promoter and Promoter Group

Anushakti Enterprise Private Limited

29,92,950 (3.3%)

Shareholding of Promoter and Promoter Group

Labdhi Business Trust(saswat Trusteeship Private Limited)

28,41,504 (3.13%)

Shareholding of Promoter and Promoter Group

Promoter sharesShareCategory
Life Insurance Corporation Of India47,82,452 (5.28%)Public Shareholding
Rashesh Chandrakant Gogri38,34,404 (4.23%)Shareholding of Promoter and Promoter Group
Jaya Chandrakant Gogri32,04,310 (3.53%)Shareholding of Promoter and Promoter Group
Anushakti Enterprise Private Limited29,92,950 (3.3%)Shareholding of Promoter and Promoter Group
Labdhi Business Trust(saswat Trusteeship Private Limited)28,41,504 (3.13%)Shareholding of Promoter and Promoter Group
Hetal Gogri Gala28,15,612 (3.11%)Shareholding of Promoter and Promoter Group
Mirik Rajendra Gogri27,93,094 (3.08%)Shareholding of Promoter and Promoter Group
Renil Rajendra Gogri25,42,750 (2.81%)Shareholding of Promoter and Promoter Group
Sarla Shantilal Shah24,35,830 (2.69%)Shareholding of Promoter and Promoter Group
Ntasian Discovery Master Fund16,60,676 (1.83%)Public Shareholding
Rajendra Vallabhaji Gogri14,25,900 (1.57%)Shareholding of Promoter and Promoter Group
Manomaya Business Trust(alabhya Trusteeship Private Limited)13,08,496 (1.44%)Shareholding of Promoter and Promoter Group
Nehal Garewal11,22,487 (1.24%)Shareholding of Promoter and Promoter Group
Nishant Pradip Shah9,97,427 (1.1%)Public Shareholding
Safechem Enterprises Private Limited8,33,000 (0.92%)Shareholding of Promoter and Promoter Group
Heena Family Private Trust(barclays Wealth Trustees India Private Limited)8,33,859 (0.92%)Shareholding of Promoter and Promoter Group
Bhavna Family Private Trust(barclays Wealth Trustees India Pvt Ltd)8,04,101 (0.89%)Shareholding of Promoter and Promoter Group
Jasmine Family Trust(relacion Trusteeship Services Private Limited)6,87,500 (0.76%)Shareholding of Promoter and Promoter Group
Nikhil Parimal Desai6,81,754 (0.75%)Shareholding of Promoter and Promoter Group
Alchemie Financial Services Limited6,73,006 (0.74%)Shareholding of Promoter and Promoter Group
Lotus Family Trust(gloire Trusteeship Services Private Limited)6,24,500 (0.69%)Shareholding of Promoter and Promoter Group
Manisha Rashesh Gogri5,50,000 (0.61%)Shareholding of Promoter and Promoter Group
Aashay Rashesh Gogri5,50,000 (0.61%)Shareholding of Promoter and Promoter Group
Aarnav Rashesh Gogri5,50,000 (0.61%)Shareholding of Promoter and Promoter Group
Arti Rajendra Gogri4,55,256 (0.5%)Shareholding of Promoter and Promoter Group
Tulip Family Trust (gloire Trusteeship Services Private Limited)3,97,500 (0.44%)Shareholding of Promoter and Promoter Group
Orchid Family Trust(relacion Trusteeship Services Private Limited)3,80,000 (0.42%)Shareholding of Promoter and Promoter Group
Parimal Hasmukhlal Desai3,49,571 (0.39%)Shareholding of Promoter and Promoter Group
Ratanben Premji Gogri3,44,332 (0.38%)Shareholding of Promoter and Promoter Group
Gogri Finserv Pvt. Ltd.3,37,505 (0.37%)Shareholding of Promoter and Promoter Group
Heena Bhatia3,22,588 (0.36%)Shareholding of Promoter and Promoter Group
Rajendra Vallabhaji Gogri (huf)[karta-rajendra Vallabhaji Gogri]3,08,274 (0.34%)Shareholding of Promoter and Promoter Group
Shantilal Tejshi Shah Huf[karta-nehal Garewal]2,78,881 (0.31%)Shareholding of Promoter and Promoter Group
Alchemie Finserv Pvt. Ltd.2,64,105 (0.29%)Shareholding of Promoter and Promoter Group
Nikhil Holdings Private Limited1,80,891 (0.2%)Shareholding of Promoter and Promoter Group
Indira Madan Dedhia1,82,250 (0.2%)Shareholding of Promoter and Promoter Group
Mananjay Singh Garewal1,62,510 (0.18%)Shareholding of Promoter and Promoter Group
Bhanu Pradip Savla1,55,737 (0.17%)Shareholding of Promoter and Promoter Group
Hetvi Rohan Ghalla1,50,000 (0.17%)Shareholding of Promoter and Promoter Group
Chandrakant Vallabhaji Gogri1,55,500 (0.17%)Shareholding of Promoter and Promoter Group
Monisha Bhatia1,21,121 (0.13%)Shareholding of Promoter and Promoter Group
Shreya Suneja1,12,500 (0.12%)Shareholding of Promoter and Promoter Group
Dinesh Devchand Ghalla1,00,000 (0.11%)Shareholding of Promoter and Promoter Group
Gunavanti Navin Shah86,644 (0.1%)Shareholding of Promoter and Promoter Group
Krisha Yogesh Nahar43,940 (0.05%)Shareholding of Promoter and Promoter Group
Aashyav Business Trust(alabhya Trusteeship Private Limited)37,900 (0.04%)Shareholding of Promoter and Promoter Group
Jayesh Shah14,957 (0.02%)Shareholding of Promoter and Promoter Group
Valiant Organics Limited7,500 (0.01%)Shareholding of Promoter and Promoter Group
Dilesh Roadlines Pvt Ltd8,318 (0.01%)Shareholding of Promoter and Promoter Group
Pooja Renil Gogri382 (0%)Shareholding of Promoter and Promoter Group
Prasadi Yogesh Banatwala4,245 (0%)Shareholding of Promoter and Promoter Group

About AARTI PHARMALABS LIMITED

Aarti Pharmalabs Limited was initially incorporated as 'Aarti Organics Limited' in 2019. The name of the Company was changed to Aarti Pharmachem Limited from Aarti Organics Limited' in July, 2021 and to Aarti Pharmalabs Limited in 2022. Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India. It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic seg

Parent Organisation

Indian Private

NSE Symbol

AARTIPHARM

Founded

2019

AARTI PHARMALABS LIMITED CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
15 Sept 20252.5Final15 Sept 2025Equity shares
14 Feb 20252.5Interim14 Feb 2025Equity shares
31 Jul 20241Final31 Jul 2024Equity shares
16 Feb 20242Interim19 Feb 2024Equity shares

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)